- The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes. Ohtake, A., Sato, S., Sasamata, M., Miyata, K. J. Pharmacol. Sci. (2010)